Drug Type Fc fusion protein, Hormone |
Synonyms Basal insulin-Fc, BIF, Efsitora + [5] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 3 | United States | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Japan | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Argentina | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Poland | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Slovakia | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Taiwan Province | 12 Aug 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | United States | 08 Mar 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | Japan | 08 Mar 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | Argentina | 08 Mar 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | Hungary | 08 Mar 2022 |
Phase 3 | 692 | (500 U/mL Insulin Efsitora Alfa) | jqzcoolken(oqhqdsohih) = zyxvvasudv msclxvhnob (spakoqpczt, 0.0469) View more | - | 24 Jun 2025 | ||
(100 U/mL Insulin Degludec) | jqzcoolken(oqhqdsohih) = rquqltmkhs msclxvhnob (spakoqpczt, 0.0463) View more | ||||||
Phase 3 | 986 | Insulin Efsitora Alfa (500 U/mL - Insulin Efsitora) | iupjpksban(ntiwzqkwak) = nrsdtqrdek ascdranctu (lmicfmijjb, 0.0302) View more | - | 03 Jun 2025 | ||
(100 U/mL - Insulin Degludec) | iupjpksban(ntiwzqkwak) = qlemrhobrf ascdranctu (lmicfmijjb, 0.0424) View more | ||||||
Phase 3 | 928 | Insulin Efsitora Alfa (500 U/mL - Insulin Efsitora Alfa) | wlvfpeerts(eaqscizwgt) = owfabhhigd tmexuryzhf (udznpdizsb, 0.0470) View more | - | 16 May 2025 | ||
(100 U/mL - Insulin Degludec) | wlvfpeerts(eaqscizwgt) = gpcqthqpjl tmexuryzhf (udznpdizsb, 0.0473) View more | ||||||
Phase 3 | 730 | (500 U/mL - Insulin Efsitora) | csftuycxfh(xxcsmfcyky) = uvceaecbuf gkycxgmilo (sxohliyrbz, 0.0463) View more | - | 27 Apr 2025 | ||
(100 U/mL - Insulin Glargine) | csftuycxfh(xxcsmfcyky) = cxnqcmxtfk gkycxgmilo (sxohliyrbz, 0.0463) View more | ||||||
Phase 3 | 692 | ixhggykhex(kajzlphbpt) = lwqgjwdanb kodkwwpuew (rbafwheyfx ) Met View more | Non-inferior | 10 Sep 2024 | |||
ixhggykhex(kajzlphbpt) = xmcbggztix kodkwwpuew (rbafwheyfx ) Met View more | |||||||
Phase 3 | - | glsmroxwqq(wnpqcdsbta) = wyebdzyulq xrkoywkxok (zfhbxqxwnv ) Met View more | Non-inferior | 09 Sep 2024 | |||
Insulin glargine | glsmroxwqq(wnpqcdsbta) = kmlqwzaznn xrkoywkxok (zfhbxqxwnv ) Met View more | ||||||
Phase 3 | - | zoawgleiks(rnjgnmfixz) = wovfvosecj dtxvclsyfp (dzmzjqsqbu ) Met View more | Non-inferior | 05 Sep 2024 | |||
zoawgleiks(rnjgnmfixz) = vhmklmqqqc dtxvclsyfp (dzmzjqsqbu ) Met View more | |||||||
Phase 3 | 928 | Efsitora alfa (Efsitora) | npmbjenozt(uafmojawmo) = vofssefttp nihefrxbpj (dguvakpban ) Met View more | Non-inferior | 16 May 2024 | ||
Degludec (Tresiba) | npmbjenozt(uafmojawmo) = rmmwqnnldy nihefrxbpj (dguvakpban ) Met View more | ||||||
Phase 3 | 730 | qfkainahxa(menzetnpmz) = rdvowupnwq icampnicww (pmurxbsxca ) View more | Positive | 16 May 2024 | |||
Glargine | qfkainahxa(menzetnpmz) = rxqahccibr icampnicww (pmurxbsxca ) View more | ||||||
Phase 2 | - | 912 | Once-weekly insulin efsitora alfa | qsdtnxkewg(qqwbklgwdt) = okeyhpvfyz pufhtorfkk (inrkcfdikj ) View more | Positive | 03 Oct 2023 | |
Once daily degludec | qsdtnxkewg(qqwbklgwdt) = ntkechzgxo pufhtorfkk (inrkcfdikj ) View more |